Heart disease is one of the leading causes of death globally. Two of the most common forms of heart disease […]
Pharmacogenetics (PGx) is the study of how an individual’s genetic makeup affects their drug response and metabolism. An understanding of PGx could help clinicians make prescribing decisions and has the potential to be implemented in routine care worldwide. PGx has understandably been gaining traction and support, with pharmacogenomic elements being implemented into many international Genomic studies.
It is well documented that the genetic risk for Alzheimer’s has a sex bias. Sex bias in Alzheimer’s Carrying a […]
Recent times has seen an influx in companies offering direct to consumer genetic tests that offer a wide range of […]
A team of researchers have analysed human proteome data from brain tissue to study whether targeted proteins predictively mediated the […]
A team of researchers have identified the largest genetic contributor to height known to date. The gene was found under […]
The direct to consumer (DTC) genetic test market has seen a decline recently over privacy concerns, but private companies such […]
The genetic basis for schizophrenia has long been studied since the first major study was released over 70 years ago, […]
Around 25% of the world is affected by a psychiatric disorder that can alter their behaviour, social relations and intellectual ability.
Aging affects everyone, right down to our genetic core, but there’s plenty of evidence showing that each individual experiences the effects of age differently. As it turns out, some people are predisposed to a less disruptive (a kinder, gentler) aging process. New research hopes to uncover why that is.
